OBJ completes 2nd phase human clinical anaesthetic trials

Leederville-based OBJ Limited is pleased to announce the successful completion of the second phase of the company's human clinical trial into the enhanced transdermal delivery of the local anaesthetic Ametop, which uses Tetracaine as its active ingredient.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE9,064
10th-The University of Notre Dame Australia6,708
46 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer